modern
life
human
alway
threaten
infecti
diseas
bacteria
viru
fungi
critic
reason
infecti
diseas
bacteria
serv
mani
diseas
food
rout
germani
escherichia
coli
fenugreek
sprout
export
egypt
caus
death
viru
could
caus
variou
diseas
includ
human
immunodefici
viru
hiv
influenza
fungi
like
cryptococcu
neoforman
could
lead
chronic
liver
diseas
luckili
develop
safe
vaccin
antibiot
infecti
diseas
seem
total
cure
therapi
howev
advers
drug
effect
patient
take
drug
common
dose
overdos
insomnia
osteoporosi
headach
liver
failur
furthermor
pathogen
fast
doubl
cycl
develop
mechan
becom
resist
specif
drug
glanc
henc
scientist
tri
find
new
approach
solv
aforement
problem
urgent
nanotechnolog
emerg
scienc
nanocarri
use
medic
applic
long
time
nanocarri
contain
drug
emerg
innov
promis
altern
drug
deliveri
target
site
also
greatli
improv
free
drug
safeti
drug
efficaci
drugladen
nanocarri
could
design
tailor
reach
intend
site
thu
pathogen
area
could
precis
cure
drug
elev
therapeut
effect
lot
signific
proof
nanocarri
superior
biocompat
target
tissu
penetr
compar
free
drug
advantag
nanoscal
drug
deliveri
system
includ
increas
bioavail
reduc
drug
amount
frequenc
reduc
system
side
effect
henc
activ
target
drug
deliveri
combin
nanotechnolog
carrier
platform
better
way
prolong
local
target
pathogen
site
reduct
drug
sideeffect
one
import
prerequisit
drug
deliveri
system
send
therapeut
agent
effect
patholog
site
soon
activ
target
strategi
prospect
approach
drug
deliveri
activ
strategi
introduc
paul
ehrlich
known
magic
bullet
describ
system
system
reach
intend
site
higher
concentr
short
period
time
activ
target
deliveri
believ
improv
efficaci
reduc
unpleas
sideeffect
certain
bacteria
fungi
virus
intracellular
parasit
grow
reproduc
insid
special
host
cell
scientist
could
creat
activ
target
drug
deliveri
system
copi
cell
infect
parasit
activ
target
strategi
use
curtain
ligand
antibodi
peptid
nanobodi
sugar
molecul
aptam
surfac
nanocarri
improv
therapeut
efficaci
common
seen
nanocarri
liposom
nanoparticl
dendrim
carbon
nanotub
other
liposom
selfassembl
spheric
vesicl
compos
amphiphil
lipid
bilay
inner
aqueou
core
frequent
use
platform
pharmaceut
cosmet
drug
releas
uniqu
dual
releas
capabl
make
deliveri
two
type
substanc
time
first
fdaapprov
liposom
drug
doxorubicinencapsul
pegyl
liposom
cure
aid
connect
kaposi
sarcoma
begun
product
compos
natur
lipid
liposom
low
toxic
eas
prepar
high
biodegrad
henc
work
well
wide
rang
agent
facilit
target
deliveri
mean
abovement
characterist
liposom
liposom
bind
differ
specif
ligand
surfac
glycerolipid
archaea
archaeosom
viru
glycoproteinantigen
virosom
could
display
immunoadjuv
potenti
vaccin
higher
affin
target
site
free
drug
detail
refer
connect
bind
ligand
treatment
diseas
result
microb
summar
tabl
nanoparticl
includ
metal
nonmet
nanoparticl
systemat
previou
review
mani
uniqu
physicochem
properti
includ
extrem
small
size
huge
surfac
mass
ratio
high
reactiv
distinct
interact
biolog
system
nanoparticl
demonstr
elev
drug
stabil
bioavail
target
uptak
particl
less
nm
rapidli
expel
circul
extravas
larger
particl
limit
diffus
extracellular
space
henc
develop
nanoparticl
contain
medicin
made
possibl
increas
therapeut
index
mani
compon
use
suit
ligand
arriv
intent
site
nanoparticl
bind
ligand
could
enhanc
antivir
activ
improv
cytotox
low
water
solubl
rapid
clearanc
circul
free
drug
detail
studi
treat
microb
nanoparticl
bind
ligand
summar
tabl
dendrim
synthes
buhleier
et
al
tomalia
et
al
dendrim
synthet
highli
branch
spheric
polym
compar
tradit
linear
polym
dendrim
much
superior
drug
carrier
also
differ
kind
dendrim
polyamidoamin
dendrim
first
one
creat
mani
outstand
properti
dendrim
monodispers
nanos
shape
biocompat
low
toxic
good
pharmacokinet
easili
provid
activ
target
drug
deliveri
dendrim
bind
ligand
result
reduc
cytotox
hemolyt
bioactiv
increas
biocompat
free
drug
detail
refer
relat
bind
ligand
treat
diseas
caus
microb
summar
tabl
carbon
nanotub
cylindr
nanostructur
consist
pure
carbon
atom
coval
bond
hexagon
array
two
kind
nanotub
singlewal
carbon
nanotub
multiwal
carbon
nanotub
carbon
nanotub
show
efficaci
drug
deliveri
vehicl
sinc
easili
intern
cell
moreov
singlewal
carbon
nanotub
high
chemic
stabil
easi
function
multiwal
carbon
nanotub
singleatom
layer
wall
carbon
nanotub
surfac
modif
continu
use
activ
target
drug
deliveri
larg
surfac
area
bound
numer
ligand
surfac
target
site
although
carbon
nanotub
wide
use
treatment
cancer
still
public
use
cure
diseas
caus
microb
compar
free
drug
carbon
nanotub
bind
differ
ligand
provid
promis
outcom
like
reduc
advers
effect
control
drug
deliveri
improv
patient
complianc
detail
refer
associ
bind
ligand
inhibit
microb
summar
tabl
although
activ
target
strategi
use
nanocarri
solv
mani
concern
convent
drug
strategi
still
challeng
report
research
activ
target
strategi
notabl
effici
approach
send
drug
toward
pathogen
organ
howev
kunjachan
et
al
report
activ
target
strategi
overestim
drug
retent
time
use
activ
target
approach
would
diminish
easili
anim
model
besid
activ
target
deliveri
need
highli
specif
target
recognit
great
deal
target
bind
affin
henc
length
branch
carri
ligand
number
ligand
per
nanocarri
consid
besid
paper
activ
target
drug
deliveri
microb
collect
vitro
scientist
could
use
vivo
model
determin
efficaci
activ
target
strategi
futur
site
specif
target
drug
lot
advantag
activ
target
drug
deliveri
system
gain
popular
present
scenario
specif
target
ligand
drug
directli
target
site
action
prevent
toxic
undesir
effect
site
use
bioavail
enhanc
drug
poor
bioavail
reduc
dose
drug
administ
consequ
activ
target
drug
deliveri
use
nanocarri
provid
guarante
cure
infecti
diseas
precis
effici
